Cardiorenal Benefit of Tirzepatide in Type 1 Diabetes: A Case Report
Patients with type 1 diabetes (T1D) who are obese are at risk of cardiovascular disease, renal diseases, and other complications. Unfortunately, there is currently no cure for T1D, necessitating individuals with this condition to rely on lifelong insulin therapy. Tirzepatide, a dual-acting glucose-d...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Wolters Kluwer Medknow Publications
2024-10-01
|
| سلاسل: | Journal of Diabetology |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://journals.lww.com/jodb/fulltext/2024/15040/cardiorenal_benefit_of_tirzepatide_in_type_1.19.aspx |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|